Issue #41 · June 24
BIO 2026 is in full swing, with Korean biotech taking center stage on the global scene 👍
From major deal-making and global expansion efforts to AI innovation, obesity therapeutics, and emerging industry trends, here's what made it into this week!
Stay tuned till the end for more K-Bio updates!
EDITOR'S NOTE
Seen the Shorts from the scene?
From the opening of Korea Pavilion to the first-ever official Korea Session at BIO, Korea IPO Conference and Korea Night, two days have already flown by!

Join us for ongoing open innovation at Korea Pavilion—and stay with us throughout the week!

Visit us at Booth #3735 😍
THIS WEEK: 
KoreaBIO MEMBER NEWS
 #New   #Welcome 
 #Members_Only 

Dx&Vx to Showcase Six Key Pipelines and Pursue Global Licensing Opportunities at BIO 2026.

JNPMEDI Unveils "Zero-Submission" Roadmap at CDISC EU Interchange 2026.

CHA Biotech and Matica Biotechnology Launch Integrated U.S.-Korea CGT Development Platform.

Trial Informatics to Host July Webinar on AI-Powered Clinical Trial Efficiency.

GCCL to Host July Webinar on Biomarker Claims, Regulatory Cases and RUO Kit Limitations.

Willog Insurance Introduces IoT Data-Based Shipment Verification for Biopharma Shipments.

MicroDigital Begins Final Validation of New Vaccine Process at Serum Institute of India.

Here's what's happening across Korea's bio industry!
WHAT'S HAPPENING
 BIO 2026 in the News! 
INNOVATION & TRENDS
∎ OliX, ABL Bio and Arrowhead are pursuing different strategies to carry siRNA and other nucleic acid drugs into the CNS. - Hit News
∎ Galux's AI-Designed Bispecific Antibody Immunotherapy Selected for National New Drug Development Project - The Asia Business Daily
∎ Competition in Obesity Drug Market Shifts Focus to Convenience and Multi-Action Treatments - Aju Press
∎ LG AI Research Center Enters Oral Obesity Drug Race with Specialized AI for Drug Development - The Asia Business Daily
∎ How New Law Will Transform Human-Derived Fat into High-Value Bio-Materials - News1
∎ 2 Korean pharmaceutical reference materials become world's 1st certified reference materials - KBR
∎ Bioeconomy Corporation strengthens Malaysia-Korea partnership through Terengganu Bio-CNG project - BioEnergy Times
∎ Pharmaceutical Industry Accelerates AI Adoption, Aiming for Doubling Profits by 2030 - Aju Press
GROWTH & PERFORMANCE
WHAT WE'VE BEEN UP TO
Interview
Jurie Hwang, Director of KoreaBIO shares insights on the real questions behind Korea's biotech rise!
At BIO USA
We opened Korea Pavilion and kicked off the event with a press briefing featuring Seung-kyou Lee, Vice President of KoreaBIO!
WHAT'S COMING UP?

Learn More? [Visit our Website]

New here? Join 2,700+ insatiably curious readers [Sign up here]

Missed Something? Check up on [Past Issues]

Korea Biotechnology Industry Organization (KoreaBIO)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea